Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 19Lung Neoplasms 10Stomach Neoplasms 8Neoplasm Metastasis 6Colorectal Neoplasms 6Breast Neoplasms 6Nasopharyngeal Carcinoma 5Leukemia, Myeloid, Acute 5Esophageal Neoplasms 5Small Cell Lung Carcinoma 4Pancreatic Neoplasms 4Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Rectal Neoplasms 2Mouth Neoplasms 2Lymphoma 2Head and Neck Neoplasms 2Glioma 2Glioblastoma 2Carcinoma, Squamous Cell 2Anatomic Stage II Breast Cancer AJCC v8 2Advanced Solid Tumors 2Unresectable Locally Recurrent Rectal Cancer 1Thymoma 1

Interventions

Biopsy 9Specimen Handling 8Magnetic Resonance Spectroscopy 6duvelisib 5Cyclophosphamide 5ruxolitinib 4Vincristine 410-propargyl-10-deazaaminopterin 4pembrolizumab 3X-Rays 3Prednisone 3Etoposide 3Doxorubicin 3tazemetostat 2sodium-iodide symporter 2cemiplimab 2belinostat 2Photons 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immunoglobulin G 2Disulfides 2Cytarabine 2Bortezomib 2Azacitidine 2venetoclax 1talimogene laherparepvec 1romidepsin 1prednylidene 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Drug Therapy × 90 days × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡